dactinomycin has been researched along with levorphanol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gavitt, J; Karmin, M; Smith, AA | 1 |
| Mueller, GC; Noteboom, WD | 1 |
1 review(s) available for dactinomycin and levorphanol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for dactinomycin and levorphanol
| Article | Year |
|---|---|
Tolerance to the lenticular effects of opiates.
Topics: Animals; Dactinomycin; Drug Tolerance; Epinephrine; Female; Lens, Crystalline; Levorphanol; Methadone; Mice; Morphine; Puromycin; Reserpine | 1967 |
Inhibition of protein and RNA synthesis in HeLa cells by levallorphan and levorphanol.
Topics: Carbon Isotopes; Culture Techniques; Dactinomycin; DNA; Guanine; HeLa Cells; Leucine; Levorphanol; Nucleotidyltransferases; Phospholipids; Protein Biosynthesis; Ribosomes; RNA; RNA, Messenger; Tritium | 1966 |